JPH0236261B2 - - Google Patents
Info
- Publication number
- JPH0236261B2 JPH0236261B2 JP62243080A JP24308087A JPH0236261B2 JP H0236261 B2 JPH0236261 B2 JP H0236261B2 JP 62243080 A JP62243080 A JP 62243080A JP 24308087 A JP24308087 A JP 24308087A JP H0236261 B2 JPH0236261 B2 JP H0236261B2
- Authority
- JP
- Japan
- Prior art keywords
- piercing
- container
- solute
- storage chamber
- needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 claims description 45
- 229940079593 drug Drugs 0.000 claims description 41
- 239000002904 solvent Substances 0.000 claims description 12
- 238000004891 communication Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 description 27
- 238000001802 infusion Methods 0.000 description 6
- 239000005022 packaging material Substances 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- YRMCBQLZVBXOSJ-PCFSSPOYSA-N (e)-3-[(6r,6as)-4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide Chemical compound CO[C@H]1NC2=C(O)C(C)=CC=C2C(=O)N2C=C(\C=C\C(N)=O)C[C@@H]12 YRMCBQLZVBXOSJ-PCFSSPOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 241000238413 Octopus Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、薬剤収納容器に関し、特に収納室内
に収納されると共に粉末状の若しくは液状の薬剤
等の溶質を収容している溶質容器内に、貯溜室内
の溶解液等の溶媒を送り、粉末状若しくは液状の
薬剤等の溶質を無菌的に溶解することが出来る薬
剤収納容器に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a drug storage container, and particularly to a solute container that is stored in a storage chamber and contains a solute such as a powdered or liquid drug. The present invention relates to a drug storage container that can aseptically dissolve solutes such as powdered or liquid drugs by sending a solvent such as a solution in a storage chamber.
多くの薬剤(溶質)は患者に静脈注射される直
前に溶解液(溶媒)に溶解される。この理由は
種々あるが、その代表的なものは、薬剤が溶解液
に溶解されるとその有効性を短期間しか維持出来
ないことである。このため、従来、溶質容器内に
収容されている抗生物質等の粉末薬剤を患者に投
与する場合
注射器にて生理的食塩水、5%ブドウ糖注射
液等の溶解液を適量吸引し、粉末薬剤を収容し
ている溶質容器内に注射器の針を刺通し、溶解
液を注入し、粉末薬剤を溶解後、注射器にて再
び吸引して患者に注射していた。
Many drugs (solutes) are dissolved in a solution (solvent) just before being injected intravenously into a patient. There are various reasons for this, but a typical one is that once a drug is dissolved in a solution, its effectiveness can only be maintained for a short period of time. For this reason, conventionally, when administering powdered drugs such as antibiotics stored in a solute container to a patient, aspirate an appropriate amount of a solution such as physiological saline or 5% glucose injection using a syringe, and then administer the powdered drug. The needle of the syringe was inserted into the solute container containing the solute, a solution was injected, and after dissolving the powdered drug, it was aspirated again with the syringe and injected into the patient.
又、粉末薬剤を収容している溶質容器と溶解
液を封入しているバツグとを、刺通針と破断部
とを保持したアダプタ(連通部)にて無菌的に
連結して、溶解液を粉末薬剤が収納されている
溶質容器に注入し、粉末薬剤を溶解し、この溶
液を再びバツグに戻し、患者に点滴静注してい
た。(特表昭59−500600号公報参照)
更に、粉末薬剤を収容している溶質容器と溶
解液を封入しているバツグと空バツグとで構成
され、これらを相互に針や破断部を有するアダ
プタにて無菌的に連結して、溶解液を前記溶質
容器に入れて粉末薬剤を溶解し、この時、空バ
ツグを空気抜きとして使用して抗生物質等を完
全に溶解し、この溶液を再びバツグに戻し、患
者に点滴静注していた。(米国特許番号、
4484920参照)。 In addition, the solute container containing the powdered drug and the bag containing the dissolution solution are connected aseptically using an adapter (communicating section) that holds a piercing needle and a broken part, and the dissolution solution is transferred. The solution was injected into a solute container containing a powdered drug to dissolve the powdered drug, and the solution was returned to the bag and administered intravenously to the patient. (Refer to Japanese Patent Publication No. 59-500600) Furthermore, it is composed of a solute container containing a powdered drug, a bag containing a dissolving solution, and an empty bag, and these are connected to each other by an adapter having a needle or a broken part. The solution is put into the solute container and the powdered drug is dissolved. At this time, the empty bag is used as an air vent to completely dissolve the antibiotic, etc., and this solution is put back into the bag. The patient was then given an intravenous drip. (U.S. Patent No.
4484920).
しかしながら、上述のような従来例ではの場
合溶解後、注射器、粉末薬剤を収容した容器を
別々に準備し、クリーンベンチ等の無菌作業を行
える設備内で、これらの操作を行なわなければな
らず、操作の煩雑さ、外部からの細菌汚染の虞も
ある。又、の場合はクリーンベンチ等の無菌設
備は必要ないものの、粉末薬剤を収容した溶質容
器とアダプタとが誤つて接続されたり、その接続
操作が煩雑であつたり、しかも、アダプタの構造
が複雑などの問題がある。更にの場合では、粉
末薬剤を含んだ溶質容器とアダプタとが誤つて接
続されたり空バツグ内に粉末薬剤を溶解した液が
入つてしまい、その液を再び溶解液の入つたバツ
グ内に戻す操作が容易でない等の問題があつた。
However, in the conventional case as described above, after dissolution, a syringe and a container containing the powdered drug must be prepared separately, and these operations must be carried out in a clean bench or other facility where sterile work can be performed. There are also complications in operation and the risk of bacterial contamination from the outside. In addition, although sterile equipment such as a clean bench is not required in this case, there are cases where the solute container containing the powdered drug and the adapter are connected incorrectly, the connection operation is complicated, and the structure of the adapter is complicated. There is a problem. In further cases, the solute container containing the powdered drug and the adapter are connected incorrectly, or the liquid containing the powdered drug is poured into an empty bag, and the operation of returning the liquid to the bag containing the solution may be necessary. There were problems such as not being easy.
そこで、本発明は上記事情に鑑みてなされたも
ので、構造が簡単なものでありながら、無菌的に
抗生物質等の粉末薬剤を溶解することが出来、誤
つて溶解液が抗生物質等の粉末薬剤を収容した溶
質容器に入らず、しかも操作が容易な薬剤収納容
器を提供することを目的とする。 Therefore, the present invention was made in view of the above circumstances, and although it has a simple structure, it is capable of dissolving powdered drugs such as antibiotics in an aseptic manner. To provide a drug storage container that does not enter a solute container containing a drug and is easy to operate.
上記問題点を解決するため、本発明の薬剤収納
容器は排出口を有し且つ内部に溶媒が封入された
貯溜室と、前記溶媒により溶解される溶質を収容
すると共に刺通針により刺通可能な刺通部を有す
る溶質容器と、前記貯溜室と溶質容器との間に介
在し、かつ前記溶質容器の刺通部を必要時刺通可
能な刺通針と前記貯溜室内にあつて必要時分離可
能であり、分離したときに前記刺通針と連通状態
となる閉塞部とから成る連通部と、前記溶質容器
の刺通部と前記刺通針とを所定の間隔をおいて連
結し、所定以上の外力が加わると前記刺通針の軸
方向に塑性変形するガイドカバーとを具備してな
り、前記溶質容器の刺通部に前記刺通針を刺通
し、且つ、前記分離可能な閉塞部を分離すること
により、前記貯溜室と前記溶質容器とを連通する
よう構成したものである。
In order to solve the above-mentioned problems, the drug storage container of the present invention has a storage chamber having a discharge port and a solvent sealed therein, and contains a solute to be dissolved by the solvent, and can be pierced by a piercing needle. a solute container having a piercing portion; a piercing needle interposed between the storage chamber and the solute container and capable of piercing the piercing portion of the solute container when necessary; and a piercing needle located within the storage chamber when necessary. a communication part that is separable and includes a closing part that communicates with the piercing needle when separated, and a piercing part of the solute container and the piercing needle are connected at a predetermined interval; a guide cover that plastically deforms in the axial direction of the piercing needle when an external force of a predetermined amount or more is applied, the piercing needle is inserted into the piercing portion of the solute container, and the separable closing portion By separating the storage chamber and the solute container, the storage chamber and the solute container are configured to communicate with each other.
〔作用〕
上記構成によれば、容器の刺通部に、密封状態
にある連通部の刺通針を所定以上の外力でガイド
カバーを刺通針の軸方向に塑性変形して刺通し、
分離可能な閉塞部を分離してこの溶質容器内に貯
溜室の溶媒を注入して、この溶質容器内の溶質を
溶解して、この溶質容器を再び貯溜室内に戻し、
この溶液は排出口から他に供給される。[Function] According to the above configuration, the piercing needle of the communicating portion in a sealed state is inserted into the piercing portion of the container by plastically deforming the guide cover in the axial direction of the piercing needle using an external force of a predetermined amount or more,
separating the separable blockage, injecting the solvent in the reservoir into the solute container, dissolving the solute in the solute container, and returning the solute container back into the reservoir;
This solution is supplied to others through the outlet.
〔実施例)
以下、本発明の実施例を添付図面に基づいて詳
述する。[Example] Hereinafter, an example of the present invention will be described in detail based on the accompanying drawings.
第1図は包材で覆われた本発明の薬剤収納容器
の斜視図、第2図は薬剤収納容器の斜視図であ
る。両図において、1は薬剤収納容器を示し、該
薬剤収納容器1は、柔軟性のある合成樹脂シート
により、相互に独立した貯溜室2と収納室3とが
一体に成形されてなる。この薬剤収納容器1は、
長方形の包材4にて全体が覆われており、この包
材4によつて貯溜室2内に封入されている後述の
溶解液(溶媒)Sの安定性が保証されている。該
貯溜室2内には溶解液S、例えば、生理的食塩水
若しくは5%ブドウ糖液が50ないし100mlが封入
されている。第2図中、貯溜室2の下部には排出
口5が設けられ、更に排出口5にはアルミキヤツ
プ6が被せられ、溶解液Sが外部に出ないように
なつている。貯溜室2の上部と前記収納室3の下
部との間には、貯溜室2内に位置して破断部(分
離可能な閉塞部)7を有すると共に収納室3内に
位置して先端に瓶針(刺通針)8を有する連通部
9が設けられている。この瓶針8は返り刃8aが
設けられ、一度刺通したあと抜けにくくなつてい
る。収納室3内にはガラス若しくは樹脂製のバイ
アル(溶質容器)10が収納され、このバイアル
10内には粉末の抗生物質(溶質)Aが入つてい
る。このバイアル10の口10aには前述の瓶針
8を刺通可能なゴム栓(刺通部)11が嵌められ
ている。又、バイアル10の口10aと第2図中
収納室3の底部3aとの間にはジヤバラ(ガイド
カバー)12が設けられている。このジヤバラ1
2は、所定以上の力が軸方向、すなわち、連通部
9の瓶針8がバイアル10の口10aに嵌められ
たゴム栓11を刺通する方向にかかると塑性変形
する材料、例えば、アルミニウム、ポリプロピレ
ン等により構成されている。このため、所定以上
の力が軸方向にかからない限り瓶針8はゴム栓1
1を刺通することがなく誤つて、バイアル10内
に溶解液Sが入ることがない。又、このジヤバラ
12により瓶針8がガイドされ、瓶針8が誤つて
ゴム栓11以外に刺通するのを防止している。 FIG. 1 is a perspective view of a drug storage container of the present invention covered with a packaging material, and FIG. 2 is a perspective view of the drug storage container. In both figures, reference numeral 1 denotes a drug storage container, and the drug storage container 1 is formed by integrally molding a storage chamber 2 and a storage chamber 3, which are independent from each other, from a flexible synthetic resin sheet. This drug storage container 1 is
The whole is covered with a rectangular packaging material 4, and the stability of the solution (solvent) S, which will be described later, sealed in the storage chamber 2 is guaranteed by this packaging material 4. In the storage chamber 2, 50 to 100 ml of a dissolving solution S, such as physiological saline or 5% glucose solution, is sealed. In FIG. 2, a discharge port 5 is provided at the lower part of the storage chamber 2, and the discharge port 5 is further covered with an aluminum cap 6 to prevent the solution S from coming out. Between the upper part of the storage chamber 2 and the lower part of the storage chamber 3, a broken part (separable closing part) 7 is located in the storage chamber 2, and a bottle is located in the storage chamber 3 at the tip. A communication portion 9 having a needle (piercing needle) 8 is provided. This bottle needle 8 is provided with a turning blade 8a, and is difficult to come out after being pierced once. A vial (solute container) 10 made of glass or resin is stored in the storage chamber 3, and a powdered antibiotic (solute) A is contained in the vial 10. A rubber stopper (piercing portion) 11 through which the bottle needle 8 described above can be inserted is fitted into the opening 10a of the vial 10. Further, a bellows (guide cover) 12 is provided between the opening 10a of the vial 10 and the bottom 3a of the storage chamber 3 in FIG. This jiyabara 1
2 is a material that plastically deforms when a predetermined force or more is applied in the axial direction, that is, in the direction in which the bottle needle 8 of the communication portion 9 pierces the rubber stopper 11 fitted into the opening 10a of the vial 10, such as aluminum; It is made of polypropylene or the like. For this reason, unless a force exceeding a predetermined value is applied in the axial direction, the bottle needle 8
1 is not pierced, and the solution S does not enter the vial 10 by mistake. Further, the bottle needle 8 is guided by this bellows 12, and prevents the bottle needle 8 from accidentally penetrating anything other than the rubber stopper 11.
尚、薬剤収納容器1の上部には孔1aが穿ら
れ、第3図dに示すように輸液スタンド13のハ
ンガー14に吊される。 A hole 1a is bored in the upper part of the drug storage container 1, and the drug storage container 1 is hung on a hanger 14 of an infusion stand 13 as shown in FIG. 3d.
薬剤収納容器1の貯溜室2は患者Mと輸液セツ
ト15により連結されるが、この輸液セツト15
は、前記排出口5に被せられたアルミキヤツプ6
を刺通する瓶針16と、タコ管17とクレンメ1
8と患者Mの血管等に刺通された静注針19と、
これらを接続するチユーブ20とから成る。すな
わち、貯溜槽2の排出口5に被せられたアルミキ
ヤツプ6に輸液セツト15の瓶針16を刺通する
ことによつて貯溜室2は患者Mに輸液セツト15
を介して連結される。 The storage chamber 2 of the drug storage container 1 is connected to the patient M by an infusion set 15.
is an aluminum cap 6 placed over the discharge port 5.
The bottle needle 16 that pierces the bottle, the octopus tube 17 and the cleanser 1
8 and an intravenous needle 19 inserted into a blood vessel or the like of patient M,
It consists of a tube 20 that connects these. That is, by piercing the bottle needle 16 of the infusion set 15 into the aluminum cap 6 placed over the discharge port 5 of the storage tank 2, the reservoir chamber 2 can be used to supply the infusion set 15 to the patient M.
connected via.
次に、上記構成になる薬剤収納容器1の使用方
法について述べる。 Next, a method of using the drug storage container 1 having the above structure will be described.
まず、収納室3内に収納されているバイアル1
0の口10aに嵌められたゴム栓11に、連通部
9の瓶針8を、所定以上の外力でジヤバラ12を
軸方向に塑性変形して刺通し(第3図a参照)、
更に連通部9の破断部7を破断して、バイアル1
0と貯溜室2とを連通部9を介して連通する(第
3図b参照)。次に、貯溜室2内に封入された溶
解液Sを、貯溜室2を上にしてバイアル10を下
にして連通部9を介してバイアル10内に注入し
て、バイアル10内の粉末の抗生物質Aを溶解す
る(第3図C参照)。粉末の抗生物質Aを溶解し
た液をバイアル10を上にして貯溜室2を下にし
て貯溜室2に戻す。上述のような操作を繰り返し
てバイアル10内の粉末の抗生物質Aを完全に溶
解する。そして、この薬剤収納容器1を覆つてい
る包材4を取り除き、この薬剤収納容器1の孔1
aを輸液スタンド13のハンガー14に通して、
薬剤収納容器1をハンガー14に吊す(第3図d
参照)。すなわち、粉末の抗生物質Aを溶解した
液の入つた貯溜室2を下にして薬剤収納容器1を
ハンガー14に吊すことになる。このあと、輸液
セツト15の静注針19を患者Mの血管等に刺通
し、瓶針16を前記排出口5に被せられたアルミ
キヤツプ6を取り外し、排出口5に刺通し、クレ
ンメ18を調節して薬剤収納容器1の貯溜室2内
の粉末の抗生物質Aを溶解した液を患者Aに点滴
静注する。 First, vial 1 stored in storage chamber 3
The bottle needle 8 of the communicating part 9 is pierced through the rubber stopper 11 fitted into the mouth 10a of the bottle by plastically deforming the bellows 12 in the axial direction with an external force of a predetermined amount or more (see FIG. 3a);
Furthermore, the broken part 7 of the communicating part 9 is broken, and the vial 1 is removed.
0 and the storage chamber 2 are communicated with each other via the communication portion 9 (see FIG. 3b). Next, the solution S sealed in the storage chamber 2 is injected into the vial 10 through the communication part 9 with the storage chamber 2 facing up and the vial 10 facing down. Dissolve substance A (see Figure 3C). A solution containing powdered antibiotic A is returned to the storage chamber 2 with the vial 10 facing up and the storage chamber 2 facing down. The above-described operation is repeated to completely dissolve the powdered antibiotic A in the vial 10. Then, the packaging material 4 covering this drug storage container 1 is removed, and the hole 1 of this drug storage container 1 is removed.
a through the hanger 14 of the infusion stand 13,
Hang the drug storage container 1 on the hanger 14 (Fig. 3d)
reference). That is, the drug storage container 1 is hung on the hanger 14 with the storage chamber 2 containing the solution containing the dissolved antibiotic A in powder form facing down. After that, insert the intravenous needle 19 of the infusion set 15 into the blood vessel of the patient M, remove the aluminum cap 6 that covers the outlet 5, insert the bottle needle 16 into the outlet 5, and adjust the clamp 18. A solution in which powdered antibiotic A is dissolved in the storage chamber 2 of the medicine storage container 1 is intravenously injected into the patient A.
第4図は本発明の他の実施例を示すもので、第
2図に示す実施例と略同一の構成であるから、同
一部分については同一記号を付してその説明を省
略する。薬剤収納容器1は、第2図に示す実施例
では柔軟性のある合成樹脂シートにて相互に独立
した貯溜室2と収納室3とが一体に成形されてい
るが、本実施例は貯溜室2と収納室3′とは別体
になつている。収納室3′は外周面がジヤバラ状
に形成された円筒状をなしている。この収納室
3′の端面には吊り具21が取り付けられている。
他の構成作用については第2図に示す実施例と同
じなので省略する。 FIG. 4 shows another embodiment of the present invention, which has substantially the same configuration as the embodiment shown in FIG. 2, so the same parts are given the same symbols and the explanation thereof will be omitted. In the embodiment shown in FIG. 2, the drug storage container 1 has a storage chamber 2 and a storage chamber 3 that are independent of each other and are integrally molded from a flexible synthetic resin sheet. 2 and the storage chamber 3' are separate bodies. The storage chamber 3' has a cylindrical shape with a bellows-shaped outer peripheral surface. A hanger 21 is attached to the end face of this storage chamber 3'.
The other structural functions are the same as those of the embodiment shown in FIG. 2, so a description thereof will be omitted.
以上詳述したように、本発明の薬剤収納容器は
排出口を有し且つ内部に溶媒が封入された貯溜室
と、前記溶媒により溶解される溶質を収容すると
共に刺通針により刺通可能な刺通部を有する溶質
容器と、前記貯溜室と溶質容器との間に介在し、
かつ前記溶質容器の刺通部を必要時刺通可能な刺
通針と前記貯溜室内にあつて必要時分離可能であ
り、分離したときに前記刺通針と連通状態となる
閉塞部とから成る連通部と、前記溶質容器の刺通
部と前記刺通針とを所定の間隔をおいて連結し、
所定以上の外力が加わると前記刺通針の軸方向に
塑性変形するガイドカバーとを具備してなり、容
器の刺通部分に密封状態にある連通部の刺通針を
所定以上の外力でガイドカバーを刺通針の軸方向
に塑性変形して刺通し、分離可能な閉塞部を分離
して、この溶質容器内に貯溜室の溶媒を注入し
て、この溶質容器内の溶質を溶解して、この溶液
を再び貯溜室内に戻し、この溶液は貯溜室内の排
出口から他に供給される。
As described in detail above, the drug storage container of the present invention has a storage chamber which has a discharge port and is filled with a solvent, and which accommodates a solute to be dissolved by the solvent and which can be penetrated by a piercing needle. a solute container having a piercing portion, interposed between the storage chamber and the solute container,
and comprises a piercing needle that can penetrate the piercing part of the solute container when necessary, and a closing part that is located within the storage chamber and can be separated when necessary, and is in communication with the piercing needle when separated. connecting a communicating portion, a piercing portion of the solute container, and the piercing needle at a predetermined interval;
The guide cover is provided with a guide cover that plastically deforms in the axial direction of the piercing needle when an external force of a predetermined amount or more is applied, and guides the piercing needle of the communicating part in a sealed state to the piercing part of the container by an external force of a predetermined amount or more. The cover is pierced by plastic deformation in the axial direction of the piercing needle, the separable blocking part is separated, and the solvent in the storage chamber is injected into the solute container to dissolve the solute in the solute container. This solution is returned to the storage chamber, and this solution is supplied to others through the outlet in the storage chamber.
従つて、本発明の薬剤容器は構成要素が少ない
から、構造が簡単であり、連通部は密封されてい
るから無菌状態になつており、更に、所定以上の
軸方向の外力がガイドカバーにかからないとガイ
ドカバーが塑性変形しないので、連通部の刺通針
は溶質容器の刺通部を刺通することがほとんどな
い。しかも空のバツグなどがないから溶解操作も
容易などの効果がある。 Therefore, the drug container of the present invention has a simple structure because it has a small number of components, and the communication part is sealed so that it is sterile, and furthermore, an external force in the axial direction that exceeds a predetermined value is not applied to the guide cover. Since the guide cover is not plastically deformed, the piercing needle of the communication portion hardly pierces the piercing portion of the solute container. Moreover, since there are no empty bags, the melting operation is easy.
第1図乃至第3図は本発明の一実施例を示し、
第1図は包材で覆われた状態の薬剤収納容器の斜
視図、第2図は第1図の包材を除いた状態の薬剤
収納容器の拡大した斜視図、第3図は薬剤収納容
器の使用状態を示す説明図、第4図は本発明の他
の実施例を示す薬剤収納容器の斜視図である。
1……薬剤収納容器、2……貯溜室、5……排
出口、7……破断部(分離可能な閉塞部)、8…
…瓶針(刺通針)、9……連通部、10……バイ
アル(溶質容器)、11……ゴム栓(刺通部)、1
2……ジヤバラ(ガイドカバー)、S……溶解液
(溶媒)、A……抗生物質(溶質)。
1 to 3 show an embodiment of the present invention,
Figure 1 is a perspective view of the medicine storage container covered with packaging material, Figure 2 is an enlarged perspective view of the medicine storage container in Figure 1 with the packaging material removed, and Figure 3 is the medicine storage container. FIG. 4 is a perspective view of a drug storage container showing another embodiment of the present invention. DESCRIPTION OF SYMBOLS 1... Drug storage container, 2... Storage chamber, 5... Outlet, 7... Broken part (separable closing part), 8...
... Bottle needle (piercing needle), 9 ... Communication part, 10 ... Vial (solute container), 11 ... Rubber stopper (piercing part), 1
2...Jiyabara (guide cover), S...Solution solution (solvent), A...Antibiotic (solute).
Claims (1)
溜室と、前記溶媒により溶解される溶質を収容す
ると共に刺通針により刺通可能な刺通部を有する
溶質容器と、前記貯溜室と溶質容器との間に介在
し、かつ前記溶質容器の刺通部を必要時刺通可能
な刺通針と前記貯溜室内にあつて必要時分離可能
であり、分離したときに前記刺通針と連通状態と
なる閉塞部とから成る連通部と、前記溶質容器の
刺通部と前記刺通針とを所定の間隔をおいて連結
し、所定以上の外力が加わると前記刺通針の軸方
向に塑性変形するガイドカバーとを具備してな
り、前記溶質容器の刺通部に前記刺通針を刺通
し、且つ、前記分離可能な閉塞部を分離すること
により、前記貯溜室と前記溶質容器とを連通する
よう構成したことを特徴とする薬剤収納容器。1. A storage chamber having a discharge port and containing a solvent therein, a solute container containing a solute dissolved by the solvent and having a piercing portion that can be pierced by a piercing needle, and the storage chamber; A piercing needle interposed between the solute container and capable of piercing the piercing portion of the solute container when necessary, and a piercing needle located within the storage chamber and separable when necessary, and when separated, the piercing needle A communication part consisting of a closed part that communicates with the piercing part of the solute container and the piercing needle are connected at a predetermined interval, and when an external force of a predetermined amount or more is applied, the piercing needle is moved in the axial direction of the piercing needle. a guide cover that is plastically deformed, and the storage chamber and the solute container are separated by piercing the piercing needle through the piercing portion of the solute container and separating the separable closing portion. A drug storage container configured to communicate with each other.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24308087A JPS6485653A (en) | 1987-09-28 | 1987-09-28 | Drug receiving container |
EP88908369A EP0395758B1 (en) | 1987-09-28 | 1988-09-27 | Separate storage container |
DE1988908369 DE395758T1 (en) | 1987-09-28 | 1988-09-27 | CONTAINER FOR SEPARATE STORAGE. |
DE3850781T DE3850781T2 (en) | 1987-09-28 | 1988-09-27 | SEPARATE STORAGE CONTAINERS. |
PCT/JP1988/000980 WO1989002730A1 (en) | 1987-09-28 | 1988-09-27 | Separate storage container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24308087A JPS6485653A (en) | 1987-09-28 | 1987-09-28 | Drug receiving container |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6485653A JPS6485653A (en) | 1989-03-30 |
JPH0236261B2 true JPH0236261B2 (en) | 1990-08-16 |
Family
ID=17098480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24308087A Granted JPS6485653A (en) | 1987-09-28 | 1987-09-28 | Drug receiving container |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0395758B1 (en) |
JP (1) | JPS6485653A (en) |
DE (1) | DE3850781T2 (en) |
WO (1) | WO1989002730A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005512734A (en) * | 2001-12-21 | 2005-05-12 | フェロサン・アクティーゼルスカブ | Hemostasis kit, method for preparing hemostatic agent, and method for promoting hemostasis |
JP2006512115A (en) * | 2002-12-17 | 2006-04-13 | デンバー バイオメディカル,インク. | Device for drawing body fluid |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411499A (en) * | 1988-01-25 | 1995-05-02 | Baxter International Inc. | Needleless vial access device |
DE3834566A1 (en) * | 1988-10-11 | 1990-04-12 | Fresenius Ag | CONTAINER FOR STERILE, SEPARATE STORAGE OF AT LEAST TWO SUBSTANCES AND FOR MIXING THEREOF |
JPH077965Y2 (en) * | 1990-11-14 | 1995-03-01 | 昭和電工株式会社 | Infusion bag |
US5776125A (en) | 1991-07-30 | 1998-07-07 | Baxter International Inc. | Needleless vial access device |
IT1251658B (en) * | 1991-10-07 | 1995-05-19 | Inge Spa | SINGLE USE DEVICE PREFERABLY FOR HYGIENE-SANITARY USE. |
US5352191A (en) * | 1991-10-25 | 1994-10-04 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
JPH05212090A (en) * | 1992-02-04 | 1993-08-24 | Material Eng Tech Lab Inc | Transfusion container |
JP3146465B2 (en) * | 1992-03-13 | 2001-03-19 | 株式会社ニッショー | Chemical injection device |
JP3256583B2 (en) * | 1992-12-10 | 2002-02-12 | 株式会社リコー | Electrophotographic toner and method for producing the same |
DE4314090C2 (en) * | 1993-04-29 | 1997-09-04 | Wolfgang Dr Vilmar | Medical cutlery for the manufacture of a drug solution |
US5547797A (en) * | 1993-08-05 | 1996-08-20 | Minolta Co., Ltd. | Developer for developing electrostatic latent images |
ES1037919Y (en) * | 1997-07-16 | 1998-11-01 | Inibsa Lab | TWO LIQUID CONTAINER CARTRIDGE. |
US5976115A (en) * | 1997-10-09 | 1999-11-02 | B. Braun Medical, Inc. | Blunt cannula spike adapter assembly |
US5989237A (en) | 1997-12-04 | 1999-11-23 | Baxter International Inc. | Sliding reconstitution device with seal |
US20050137566A1 (en) | 2003-12-23 | 2005-06-23 | Fowles Thomas A. | Sliding reconstitution device for a diluent container |
AR021220A1 (en) | 1998-09-15 | 2002-07-03 | Baxter Int | CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER. |
DE10005813A1 (en) * | 2000-02-10 | 2001-08-23 | Wolfgang Vilmar | Mixing unit comprises container which is housed in hollow cylinder in further, axially displaceable hollow cylinder provided at its lower end with rubber membrane |
US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
CN1739017B (en) | 2002-12-11 | 2011-04-06 | 弗罗桑医疗设备公司 | Gelatine-based materials as swabs |
WO2005030111A1 (en) | 2003-09-30 | 2005-04-07 | Coloplast A/S | A wound care device |
US7641851B2 (en) | 2003-12-23 | 2010-01-05 | Baxter International Inc. | Method and apparatus for validation of sterilization process |
CA2554994C (en) | 2004-01-30 | 2015-05-19 | Ferrosan A/S | Haemostatic sprays and compositions |
DE102004021990B3 (en) * | 2004-05-04 | 2005-11-10 | Fresenius Kabi Deutschland Gmbh | Medical container for administering a liquid consisting of a carrier solution and a medicament comprises a chamber provided with means for delivery of the medicament into the chamber holding the carrier solution |
US7520919B2 (en) | 2004-06-22 | 2009-04-21 | Gambro Lundia Ab | Transducer-protector device for medical apparatus |
WO2006005340A1 (en) | 2004-07-09 | 2006-01-19 | Ferrosan A/S | Haemostatic composition comprising hyaluronic acid |
US8967374B2 (en) | 2006-05-18 | 2015-03-03 | Dr. Py Institute Llc | Delivery device with separate chambers connectable in fluid communication when ready for use, and related method |
WO2009109194A2 (en) | 2008-02-29 | 2009-09-11 | Ferrosan A/S | Device for promotion of hemostasis and/or wound healing |
FR2975302B1 (en) | 2011-05-18 | 2013-05-10 | Fresenius Medical Care De Gmbh | CONNECTOR FOR DIALYSIS CONTAINER, CONTAINER HAVING SUCH CONNECTOR, METHOD FOR MANUFACTURING AND FILLING SUCH CONNECTORS AND CONTAINERS |
FR2978914B1 (en) * | 2011-08-11 | 2013-08-16 | Fresenius Medical Care De Gmbh | CONTAINER FOR DIALYSIS |
RU2616261C2 (en) * | 2011-12-29 | 2017-04-13 | Оцука Фармасьютикал Фэктори, Инк | Protective shall, portective module, equipped with such shell, medical solution supply system and method for medical solution delivery |
CA2865349C (en) | 2012-03-06 | 2021-07-06 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
JP6394916B2 (en) | 2012-06-12 | 2018-09-26 | フェロサン メディカル デバイシーズ エイ/エス | Dry hemostatic composition |
US9724078B2 (en) | 2013-06-21 | 2017-08-08 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
EP3079731B1 (en) | 2013-12-11 | 2018-08-08 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
ES2629294T3 (en) | 2014-07-02 | 2017-08-08 | Paolo Gobbi Frattini S.R.L. | Flexible container with a sterile and hermetic chamber for the reconstitution and administration of instillable fluid medicinal or nutritional substances in a patient's body |
BR112017007466B1 (en) | 2014-10-13 | 2021-03-02 | Ferrosan Medical Devices A/S | method for preparing a dry composition, method for reconstituting the dry composition, paste, dry composition, container, homeostatic kit, and, using a dry composition |
CA2970710A1 (en) | 2014-12-24 | 2016-06-30 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
US10918796B2 (en) | 2015-07-03 | 2021-02-16 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
US9456956B1 (en) * | 2015-09-29 | 2016-10-04 | Siemens Medical Solutions Usa, Inc. | Aseptic assembling of pharmaceutical containers |
JP7003493B2 (en) * | 2017-08-28 | 2022-02-04 | ニプロ株式会社 | Standard reagent kit for dialysate analysis |
JP6642339B2 (en) * | 2016-08-30 | 2020-02-05 | ニプロ株式会社 | Standard reagent kit for dialysate analysis |
US20190192556A1 (en) * | 2016-08-30 | 2019-06-27 | Nipro Corporation | Standard reagent kit for analysis of dialysis fluid, and aqueous solutions for standard reagent, dialysis fluid and substitution fluid for artificial kidney |
EP3427781B1 (en) * | 2017-07-11 | 2024-09-25 | Pharma Resources GmbH | Drug and device system for pressurized aerosol therapies into a mammalian hollow space |
WO2019197647A1 (en) * | 2018-04-13 | 2019-10-17 | Fresenius Kabi Ab | Container for a mixing system, mixing system for parenteral nutrition, and method for mixing |
CN112020345A (en) * | 2018-04-13 | 2020-12-01 | 费森尤斯卡比股份公司 | Apparatus and method for providing a preparation for parenteral nutrition |
AU2019266529B2 (en) | 2018-05-09 | 2024-05-23 | Ethicon Inc. | Method for preparing a haemostatic composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS561559Y2 (en) * | 1976-08-12 | 1981-01-14 | ||
CA1171030A (en) * | 1979-11-05 | 1984-07-17 | David Bellamy | Fluid transfer assembly |
US4589879A (en) * | 1983-11-04 | 1986-05-20 | Baxter Travenol Laboratories, Inc. | Cannula assembly having closed, pressure-removable piercing tip |
JPS61260772A (en) * | 1985-05-14 | 1986-11-18 | Mitsubishi Electric Corp | Picture defect compensation device |
JPH0614708Y2 (en) * | 1989-10-17 | 1994-04-20 | ホシザキ電機株式会社 | Beverage warmer / cooler |
-
1987
- 1987-09-28 JP JP24308087A patent/JPS6485653A/en active Granted
-
1988
- 1988-09-27 WO PCT/JP1988/000980 patent/WO1989002730A1/en active IP Right Grant
- 1988-09-27 DE DE3850781T patent/DE3850781T2/en not_active Expired - Fee Related
- 1988-09-27 EP EP88908369A patent/EP0395758B1/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005512734A (en) * | 2001-12-21 | 2005-05-12 | フェロサン・アクティーゼルスカブ | Hemostasis kit, method for preparing hemostatic agent, and method for promoting hemostasis |
JP2006512115A (en) * | 2002-12-17 | 2006-04-13 | デンバー バイオメディカル,インク. | Device for drawing body fluid |
Also Published As
Publication number | Publication date |
---|---|
EP0395758A4 (en) | 1990-12-27 |
WO1989002730A1 (en) | 1989-04-06 |
EP0395758B1 (en) | 1994-07-20 |
EP0395758A1 (en) | 1990-11-07 |
DE3850781T2 (en) | 1995-02-23 |
DE3850781D1 (en) | 1994-08-25 |
JPS6485653A (en) | 1989-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0236261B2 (en) | ||
EP0282545B1 (en) | Connector and a disposable assembly utilizing said connector | |
JP4549680B2 (en) | Fluid transfer assembly | |
US5897526A (en) | Closed system medication administering system | |
US4838875A (en) | Method and apparatus for dealing with intravenous fluids | |
KR960005820B1 (en) | Drug delivery cartridge with protective cover | |
EP0598918A1 (en) | Medical container | |
US20010047162A1 (en) | Injection kit and injection device | |
US4475914A (en) | Medicament container and transfer device | |
EP0533171A1 (en) | Transfusion device | |
JPH05212090A (en) | Transfusion container | |
WO1997039720A1 (en) | Container closure system | |
WO2000063088A1 (en) | Cap for container and adaptor for liquid communication | |
JPH06239352A (en) | Solution injection set | |
JP2002539891A (en) | Containers for packing medical liquids | |
JPS6072561A (en) | Two-drug component syringe having vein display capacity | |
US3938518A (en) | Syringe attachment device | |
JPH07213585A (en) | Admixture injection adapter | |
US5122126A (en) | Nozzle member provided with sealing membrane | |
JPH0642676Y2 (en) | Infusion bag | |
JPH09299484A (en) | Syringe spray pump | |
JP3003949B2 (en) | Medical container | |
JP2732610B2 (en) | Medical liquid storage container | |
JP3025851B2 (en) | Aseptic holding and mixing device for two drugs housed in individually sealed containers | |
JP2710414B2 (en) | Injection solution dissolver |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |